These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 441683)

  • 1. Kinetics of the agglutination of IgG-coated latex particles by C1q: the influence of heat-labile serum components.
    Hällgren R; Stålenheim G; Venge P
    Scand J Immunol; 1979; 9(4):365-72. PubMed ID: 441683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic measurement of the interaction of rheumatoid factor with IgG-coated latex particles and the influence of the first component of human complement.
    Hällgren R
    Clin Exp Immunol; 1980 Jan; 39(1):154-63. PubMed ID: 6771071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo.
    Hällgren R
    Immunology; 1979 Nov; 38(3):529-37. PubMed ID: 118112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The macromolecular structure of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):488-94. PubMed ID: 807640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic studies of the association of complement components and IgG-coated latex particles incubated in normal or complement-activated human serum.
    Hällgren R
    Clin Exp Immunol; 1981 Apr; 44(1):191-200. PubMed ID: 7261475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.
    Thiel S; Petersen SV; Vorup-Jensen T; Matsushita M; Fujita T; Stover CM; Schwaeble WJ; Jensenius JC
    J Immunol; 2000 Jul; 165(2):878-87. PubMed ID: 10878362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the reactivity of corneal collagen and subcomponent C1q of the complement system with human platelets and IgG-coated latex particles.
    Csako G; Suba EA; Herp A
    Exp Eye Res; 1983 Mar; 36(3):403-14. PubMed ID: 6601020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of C1 subcomponents in platelet aggregation induced by aggregated IgG].
    Wautier JL; Souchon H; Peltier AP; Caen JP
    Ann Immunol (Paris); 1977; 128(1-2):81-2. PubMed ID: 848910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Visualization of the Interaction between Complement Component C1 and Immunoglobulin G: The Effect of C
    Yanaka S; Nishiguchi S; Yogo R; Watanabe H; Shen J; Yagi H; Uchihashi T; Kato K
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the nature of heat-labile anti-complementary activity in normal human serum.
    Soltis RD; Hasz D; Morris MJ; Wilson ID
    Clin Exp Immunol; 1979 Aug; 37(2):310-22. PubMed ID: 315288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on biological activities of subcomponents C1q of the first component of human, bovine, mouse and guinea-pig complement.
    Sasaki T; Yonemasu K
    Biochim Biophys Acta; 1984 Mar; 785(3):118-22. PubMed ID: 6608375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of C1q functions by RHP, a protein elevated in sera from patients with rheumatoid arthritis.
    Rosano CL; Braun CB; Hechemy KE; Parhami N; Satoh PS; Hurwitz C
    Complement; 1988; 5(2):57-64. PubMed ID: 3259913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunofluorescence studies on the subcomponents of the first component of complement (C1): detection of C1q and C1s in different cells of biopsy material and on human as well as on guinea pig peritoneal macrophages.
    Loos M; Storz R; Müller W; Lemmel EM
    Immunobiology; 1981; 158(3):213-24. PubMed ID: 7011949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of EDTA and citrate on the functional activity of the first component of complement, C1, and the C1q subcomponent.
    Zapf S; Loos M
    Immunobiology; 1985 Sep; 170(3):123-32. PubMed ID: 3932188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.